Exosome treatment for peritoneal dialysis failure
Part of Kidney & urinary clinical trials.
This trial tests whether exosomes from stem cells can help people whose peritoneal dialysis is no longer working well. It may improve fluid removal and reduce symptoms like swelling.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been on peritoneal dialysis for more than 1 year.
- You are 18 years or older.
- Your peritoneal dialysis is not removing enough fluid, as shown by tests or symptoms like swelling or heart failure.
- You do not have cancer, active infections, severe liver disease, or severe heart failure.
- You have not had peritonitis in the last 3 months and do not have it now.
- You are not pregnant or planning to become pregnant, and you are not in another drug trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special cell-free therapy (called MSC-EVs) can help people recover after a liver transplant for acute-on-chronic liver failure. It uses tiny particles from stem cells that may reduce inflammation and improve liver function.
This trial tests whether stem cell particles (called exosomes) can help people recover from multiple organ failure after emergency aortic dissection surgery. If you've had this surgery and your organs are struggling, this treatment might help them heal.
This trial tests whether a type of stem cell therapy can help people with chronic kidney disease caused by diabetes or high blood pressure. It may slow down kidney damage and improve kidney function.
This trial studies whether a natural substance called exosomes, derived from stem cells, can help reduce pain and improve function in people with knee osteoarthritis. It may be an option if other treatments have not worked well for you.
This study tests a new treatment using exosomes (tiny particles from stem cells) given through a vein to people who recently had an ischemic stroke. It aims to see if this treatment is safe and helps improve recovery.
This study tests whether exosomes (tiny particles from stem cells) can help improve blood sugar control in people with type 2 diabetes. It may offer a new way to manage the condition.
Hear when a new Peritoneal Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.